Business Wire11d
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent ...
ETF Daily News11d
What is Zacks Research’s Estimate for Qiagen Q1 Earnings?
Qiagen (NYSE:QGEN – Free Report) – Investment analysts at Zacks Research cut their Q1 2025 earnings per share estimates for Qiagen in a research note issued on Wednesday, February 26th.